Akero Therapeutics Inc (AKRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AKRO | CRSP | ERAS | ||
| Company | Akero Therapeutics Inc | Crispr Therapeutics Ag | Erasca Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 54.52 | 46.18 | 14.53 | ||
| High | 54.83 | 46.92 | 14.85 | ||
| Low | 54.37 | 45.12 | 13.86 | ||
| Latest | 54.65 | 46.63 | 14.68 | ||
| Change | +0.10 | -0.25 | +0.36 | ||
| % Change | +0.18% | -0.53% | +2.51% | ||
| Volume | 15,312,200 | 540,831 | 1,388,001 | ||
| 20-Day Average Volume | 2,420,955 | 2,394,801 | 5,361,807 | ||
| Previous Close | 54.55 | 46.88 | 14.32 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 54.38 | 53.10 | 14.49 | ||
| 20-Day Raw Stochastic | 78.26% | 9.15% | 51.05% | ||
| 20-Day Relative Strength | 65.57 | 41.12 | 61.23 | ||
| Weighted Alpha | +16.80 | +8.70 | +577.69 | ||
| Today's Opinion | 100% Buy | 88% Sell | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Sell | 88% Buy | ||
| Last Month's Opinion | 88% Buy | 72% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.39% since 12/01/25 | -6.45% since 03/17/26 | +9.73% since 03/17/26 | ||
| Low | 54.29 on 12/05/25 | 45.36 on 03/24/26 | 13.16 on 03/18/26 | ||
| High | 54.83 on 12/08/25 | 49.50 on 03/18/26 | 15.46 on 03/20/26 | ||
| 1-Month | |||||
| %Chg | +1.13% since 11/07/25 | -17.46% since 02/24/26 | +7.71% since 02/24/26 | ||
| Low | 54.02 on 11/10/25 | 45.36 on 03/24/26 | 12.84 on 02/26/26 | ||
| High | 54.83 on 12/08/25 | 61.76 on 02/26/26 | 16.41 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +22.62% since 09/08/25 | -17.37% since 12/24/25 | +327.41% since 12/24/25 | ||
| Low | 41.77 on 09/15/25 | 45.36 on 03/24/26 | 3.36 on 12/26/25 | ||
| High | 54.83 on 12/08/25 | 61.76 on 02/26/26 | 16.41 on 03/10/26 | ||
| 6-Month | |||||
| %Chg | +0.68% since 06/06/25 | -23.24% since 09/24/25 | +667.54% since 09/24/25 | ||
| Low | 41.77 on 09/15/25 | 45.36 on 03/24/26 | 1.77 on 09/25/25 | ||
| High | 57.35 on 06/27/25 | 78.48 on 10/08/25 | 16.41 on 03/10/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,499,006 | 4,499,777 | 4,450,656 | ||
| Shares Outstanding, K | 82,324 | 95,985 | 310,800 | ||
| Annual Sales | 0 | 3,510,000 | 0 | ||
| Annual Net Income | -252,060,000 | -581,600,000 | -124,550,000 | ||
| Last Quarter Sales | 0 | 860,000 | 0 | ||
| Last Quarter Net Income | -81,570,000 | -130,610,000 | -29,090,000 | ||
| 60-Month Beta | -0.40 | 1.71 | 1.16 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.99 on 11/07/25 | -1.37 on 02/12/26 | -0.10 on 03/12/26 | ||
| Latest Earnings Date | 02/27/26 | 05/05/26 | 05/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||